Optimal management of brain metastases in oncogenic-driven non-small cell lung cancer (NSCLC)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Optimal management of brain metastases in oncogenic-driven non-small cell lung cancer (NSCLC)

Published:2019-03 Issue: Volume:129 Page:63-71
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Andratschke Nicolaus,Kraft Johannes,Nieder Carsten,Tay Rebecca,Califano Raffaele,Soffietti Riccardo,Guckenberger Matthias

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference119 articles.

1. Management of brain metastases;Posner;Rev. Neurol. (Paris),1992

2. Management of brain metastases;Wen;Oncology (Williston Park, N.Y.),1999

3. Demographics of brain metastasis;Johnson;Neurosurg. Clin. N. Am.,1996

4. Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases;Sperduto;J. Clin. Oncol.,2012

5. The palliation of brain metastases: final results of the first two studies by the Radiation Therapy Oncology Group;Borgelt;Radiat. Oncol. Biol.,1980

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How we treat octogenarians with brain metastases;Frontiers in Oncology;2023-08-08

2. Efficacy of combined PD-1 immune therapy and chemotherapy in the treatment of locally advanced nonsmall cell lung cancer;Tropical Journal of Pharmaceutical Research;2023-06-06

3. Predicting survival after radiosurgery in patients with lung cancer brain metastases using deep learning of radiomics and EGFR status;Physical and Engineering Sciences in Medicine;2023-03-01

4. The role of brain radiotherapy for EGFR- and ALK-positive non-small-cell lung cancer with brain metastases: a review;La radiologia medica;2023-02-14

5. Factors Affecting 2-Year Survival in Patients With Non–Small Cell Lung Cancer Brain Metastases: Evidence from Indonesia’s National Cancer Center, Jakarta, Indonesia;Clinical Medicine Insights: Oncology;2023-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3